|
HS Code |
623621 |
| Inci Name | Sodium Hyaluronate |
| Product Name | Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate |
| Appearance | Clear to slightly yellowish liquid |
| Solubility | Water-soluble |
| Molecular Weight | 0.8-1.5 kDa |
| Method Of Production | Enzymatic degradation |
| Particle Size | <50 nm |
| Main Function | Deep skin hydration |
| Application | Cosmetics and personal care |
| Stability | Stable in a wide pH range (3-11) |
| Preservation | Contains preservative or can be preserved |
| Origin | Biotechnology-derived from microbial fermentation |
| Biocompatibility | High |
| Odor | Odorless |
| Use Level | 0.05-2% |
As an accredited Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a sealed, white foil pouch labeled “Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate, 10g,” featuring lot number and expiry date. |
| Shipping | Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate is securely packaged in sealed, moisture-resistant containers to ensure product stability and purity during transit. The shipment is handled according to standard chemical transportation guidelines, with clear labeling and documentation provided for safe and compliant delivery to the destination. |
| Storage | Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate should be stored in a cool, dry place, away from direct sunlight and moisture. Keep the container tightly sealed to prevent contamination and degradation. Ideal storage temperature is between 2°C and 8°C. Avoid exposure to excessive heat and strong oxidizing agents. Store in original packaging until use for maximum stability and efficacy. |
|
As the direct manufacturer of Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate, we directly supply core industrial customers across advanced biomedical, personal care, wound healing materials, ophthalmic solutions, and transdermal drug delivery sectors. Our focus on controlled enzymatic cleavage and nanoscale particle distribution has enabled precise optimization for downstream production requirements. Below, please find detailed descriptions of each key application scenario as realized by industry leaders, including formal compliance adherence, integration points, formulation ranges, and end product categories. In medical aesthetics, our oligomeric sodium hyaluronate is utilized for next-generation crosslinked injectable formulations requiring enhanced tissue integration with minimized inflammatory response. The nano-grade molecular profile permits highly controlled viscosity, superior particle dispersibility, and predictable in situ degradation kinetics compared to higher molecular weight grades. Direct sourcing ensures consistency from lot to lot, allowing for stable gel suspension before crosslinking and syringe filling lines. Industry compliance standards Typical usage ratio
Downstream process integration
Final product types
2. Wound Dressing Hydrogels and Bioactive Wound CareIndustrial wound dressing converters require fast-dissolving, low-molecular, and high-purity hyaluronate fractions for incorporation into antimicrobial, re-epithelializing, and moist wound healing films. Our enzyme-cleaved nano-oligomers support rapid granulation and exudate absorption, aiding manufacturers in optimizing swelling index and patient comfort while reducing batch-to-batch variation in crosslinked or composite hydrogel matrices. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Ophthalmic Eye Drop SolutionsFor ophthalmic solution manufacturers, the ultra-low endotoxin, nano-enzyme cleaved hyaluronate ensures reliable hydration, tear film stabilization, and lubricity at physiological osmolarity. As a manufacturer, we consistently meet the high-purity and particulate control required by sterile single-use or multi-dose filling lines, supporting preservation-free systems and strictly controlled viscosity adjustment for patient comfort and extended wear contact lenses. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Transdermal and Topical Pharmaceutical PreparationsManufacturers formulating transdermal delivery patches and topical semi-solid dosage forms prefer nanograde oligomeric hyaluronate to enhance skin permeation, bioadhesion, and facilitate active molecule diffusion. The specific cleavage profile we achieve increases percutaneous uptake while maintaining desirable rheological attributes for automated patch coating, topical microemulsion, or hydrogel production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. High-Performance Personal Care Serums and LotionsPremium cosmetic producers rely on enzyme-cleaved nano hyaluronate for anti-aging and hydration serums requiring immediate skin penetration and a light, non-tacky feel. Controlled oligomerization maximizes water-binding while minimizing polymer chain stacking, allowing for clear, non-precipitating formulations stable to repeated temperature cycling during bulk mixing and filling. Strict sensory panel QC ensures texture consistency across high-batch volumes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years of hands-on innovation in bioactive materials have shaped our understanding of hyaluronic acid. At our facility, the crafting of Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate reflects a commitment to what the science and industry actually need—an ingredient that distinguishes itself through both its properties and the consistent quality that emerges from sound manufacturing practices. We maintain control over every step, from raw selection through to the final tests, so product integrity doesn’t get compromised.
For those unfamiliar, sodium hyaluronate forms the sodium salt base of hyaluronic acid, a molecule found in connective, epithelial, and neural tissues. Decades ago, the biomedical field shifted from using high-molecular weight varieties to more specialized forms. Our long course in this business showed us that as cutting-edge research demanded faster skin penetration, stronger biological signaling, and improved product stability, newer forms like enzymatically-derived oligomers consistently outperformed both standard and chemically hydrolyzed types.
Nano HA® is the result of enzymatic cleavage—an approach selected because it preserves the native structure of the polysaccharide chains rather than breaking them down through heat or aggressive acid. Enzymes work selectively, producing a distribution of oligomers of targeted molecular weights, which we routinely verify using gel permeation chromatography—here, real-world technical oversight means specifications aren’t just numbers on paper but a reflection of what arrives in your lab or manufacturing line every time.
Unlike random acid hydrolysis, enzymatic cleavage avoids introducing unwanted side-reactions. We address an industry-wide frustration: acid-hydrolyzed low-molecular sodium hyaluronate batches can sometimes show depolymerization artifacts or ring-opening byproducts. Our process, using controlled enzyme lots sourced from established biotech partners, achieves not only higher reproducibility but also very low levels of endotoxin and heavy metal residues—parameters closely watched by clinical research, injectables, and dermal formulation teams.
Years of sourcing premium raw materials taught us that the original hyaluronic acid quality predetermines downstream oligomer and nano-fragment purity. The profile of oligomeric fractions depends not just on the enzymatic process, but also on the source tissue: non-animal derived, pharmaceutical-grade precursors bring a consistently low protein and allergen profile. Batch control here is relentless, with microbial contamination panels and bio-burden results released for each lot.
During the enzyme-driven cleavage, monitoring the reaction at every stage using both traditional reducing sugar assays and high-resolution chromatograms gives us confidence in the final size range. Our production environment runs on GMP principles, so traceability isn’t optional—it’s built in. Every batch records not just processing conditions but also environmental controls, ensuring consistent product and minimal batch-to-batch variability.
There’s no single best molecular weight for all applications, so we define our Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate by a combination of low molecular weights (often in the range of 500-5000 Daltons) with tight size distribution. We find, through both independent studies and our own evaluation, that oligomeric sodium hyaluronate in this window enhances tissue permeability and short-term moisturization effects.
Tighter size distribution translates to predictable hydration and biocompatibility in transdermal delivery and injectables. The clear, water-soluble powder dissolves rapidly and completely, giving formulation scientists flexibility without the guesswork found in more heterogeneous acid-hydrolyzed grades. No gels or undissolved residues show up even at low temperatures or higher concentrations, qualities that matter when the application moves from bench to actual clinical usage.
Not every low molecular weight sodium hyaluronate is genuinely an oligomer or carries the same biological impact. In our own comparative tests, formulations using enzyme-cleaved oligomers absorb faster and trigger more reliable biological outcomes—ranging from upregulated CD44 expression to improved transdermal water loss scores.
Vast clinical literature now links oligomeric hyaluronate fragments not only to improved skin hydration, but also to enhanced wound healing and anti-inflammatory effects. Most fascinating for formulators is that these benefits emerge at much lower dosages, which reduces raw material cost per product unit—a simple practical gain.
Chemically fragmented or random low-molecular hyaluronate sometimes results in an unpredictable mix of chain lengths, which impacts batch-to-batch consistency in topical and especially injectable applications. Consistent control over fragment size with enzymatic techniques ensures we don’t just claim reproducibility—we deliver it, based on published third-party verification and our own in-house analytics.
Manufacturing has a front-row seat to where sodium hyaluronate actually ends up. Oligomeric, nano-sized versions like our Nano HA® have proven their merit in applications that require more than superficial skin effects. For topical dermal patches, rapid transdermal migration means users will feel and see changes within hours, not days, aligning with consumer product testing feedback we receive.
In injectables, the ultra-low endotoxin and defined size make regulatory compliance easier—requirements have become stringent in many jurisdictions, and our experience with dossier support reflects this. The stable solution profiles of enzyme-cleaved grades allow easier co-formulation with other actives, peptides, or vitamins, often demanded in next-generation cosmetic and medical products.
We see steady growth in oral supplements relying on oligomeric hyaluronate to reach systemic circulation, supported by new pharmacokinetic studies showing higher absorption rates versus standard products. This has translated into customer demand for food-grade Nano HA® with precise labeling and trace contaminant control.
We've developed and produced traditional HA grades for decades before moving large parts of our capacity to enzyme-cut nanofragment types. The differences are not just on paper. Standard high-molecular weight HA works for viscoelastic eye drops or as a bulk moisturizer, but falters in speed and depth of cellular penetration. Oligomeric, nano-sized specimens enter the skin barrier rapidly, bind more effectively with cell receptors, and offer faster, deeper hydration.
Acid-hydrolyzed low-molecular HA, which some producers market as “oligos” without controlled processing, typically carries higher content of degraded byproducts. This not only affects shelf stability but also introduces off-colors and olfactory notes that cannot be masked in pure formulations. We routinely qualify our lots against industry-standard tests for UV absorption, residual organics, and protein fragments absent in genuine enzymatically cleaved oligomeric forms.
In manufacturing, numbers and analytical profiles guide decisions far more than marketing claims. Our GPC and HPLC data show clear differences in polydispersity index compared to non-enzymatic grades, and our products undergo profiling for NMR-confirmed terminal disaccharide units, verifying active chain ends that play a role in receptor interactions.
Enzyme treatment used in the Nano HA® process ensures the preservation of β-(1→4) and β-(1→3) linkages, a subtlety with a large effect at the cellular level. Our understanding, built on both scientific literature and repeated bioactivity assays, is that these preserved structures facilitate stronger interactions with dermal fibroblasts and epithelial cells, rather than acting as inert fillers.
Our quality control team tracks moisture content, pH in solution, protein content, and heavy metal residues using validated methods, reporting these in every lot released. Deviations even slightly outside the specification range are investigated, and corrective actions logged for full traceability. End-users get full documentation to meet rising global regulatory standards—reflecting a focus on partnership rather than simply sale and supply.
Rising demand in clinical and regulated markets means safety documentation cannot play catch-up to the market. For topical, oral, and injectable applications, we routinely compile and supply safety dossiers showing low endotoxin, negative microbial tests, identity verification by HPLC, and origin traceability. Custom manufacturing records allow buyers to meet evolving registration and GMP needs, often under tight timelines.
Every lot passes sterility and pyrogen testing, and residual solvents are tracked well below global regulatory limits. New or evolving requirements, such as those related to nitrosamine content, are faced head-on; analytic teams evolve protocols in line with what real-world usage and regulatory review panels demand.
We collaborate with formulation chemists, contract manufacturers, and clinical teams who require Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate to do more than simply hydrate. Projects focusing on skin barrier restoration, micro-needling recovery serums, and functional food products have all leveraged the narrowly defined molecular weight distribution and clean profile unique to enzymatic processing.
Feedback from real-world development teams often speaks less to abstract “performance” and more to workability: clear solutions, low dust during blending, and consistent viscosity profile even under repeated freeze/thaw or autoclave cycles. This functionality only results when structural integrity and purity aren’t compromised along the process chain.
The high degree of process control and raw material quality means Nano HA® carries a higher input cost than off-the-shelf, chemically hydrolyzed types. Large-scale buyers often question the premium, but over years of supporting product launches, we've seen that fewer formulation failures, improved shelf stability, and lower rejection rates in clinical and consumer testing more than offset these costs. No short cuts are taken, so claims made about purity or degree of polymerization have standing in scientific and regulatory settings.
Another technical challenge is the need for ultra-low endotoxin levels in injectable and mucosal applications. In our own protocols, rigorous depyrogenation steps, regular validation of water and surface systems, and third-party reference checks keep finished Nano HA® within the strictest FDA, EMA, and PMDA thresholds—real, non-negotiable standards for advanced products globally.
Nano HA® wasn’t developed in a vacuum. Our technical sales and R&D support teams attend global industry conferences and maintain direct contact with academic groups continuously publishing on newest bioactivity findings. Customer feedback directly shapes process and specification tweaks. For example, requests from advanced wound care manufacturers for oligomeric sodium hyaluronate below 2000 Da drove us to develop custom hydrolysis and fractionation protocols. Results consistently outperformed legacy products not only in bench tests, but also in actual clinical outcomes as reported by end-users.
We recognize that every production lot of Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate becomes part of a downstream medical device, skincare line, or oral supplement reaching people with real needs. Our focus isn’t just technical—it’s centered around the needs of partners who rely on dependable, traceable, high-purity oligomeric sodium hyaluronate for their own innovations to succeed.
Having walked the long road from chemical process controls to quality assurance and documentation, we know that no one-size-fits-all product exists where skin health, clinical outcomes, and next-generation materials are concerned. So we continue to invest in production innovation, stringent material sourcing, and open communication across the supply chain. This ensures every batch of Nano HA® serves as a building block, adding value and reliability to both established and emerging markets in Pharmaceuticals, Cosmeceuticals, and Nutraceuticals worldwide.
Just as science never stands still, neither does manufacturing. We invite open dialogue with developers, researchers, and formulation teams facing unresolved technical challenges—whether in improving product safety, final appearance, sensory feel, or clinical outcome. Our direct experience in enzyme cleaving, fractionating, and purifying sodium hyaluronate means we can respond with evidence-based data, practical supply solutions, and real accountability.
For us, Nano HA® Enzyme-Cleaved Oligomeric Sodium Hyaluronate is more than a commodity. It is the culmination of our technical journey, feedback-driven improvement, and shared industry progress. We remain committed to supporting the next generation of high-performance formulations with transparency and integrity, shaped by what is asked of us, and always ready to evolve with our partners and clients.
